Anhang 4: Literaturverzeichnis

[1] Bombeli, T.; Mueller, M. und Haeberli, A. (1997): Anticoagulant properties of the vascular endothelium, Thromb Haemost, (Band 77), No. 3, Seite 408-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9065986

[2] Griendling, K. K. und Alexander, R. W. (1997): Oxidative stress and cardiovascular disease, Circulation, (Band 96), No. 10, Seite 3264-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9396412

[3] Gimbrone, M. A., Jr. (1995): Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis, Am J Cardiol, (Band 75), No. 6, Seite 67B-70B. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7532351

[4] Grodos, D. und Tonglet, R. (1994): Scandinavian simvastatin study (4S), Lancet, (Band 344), No. 8939-8940, Seite 1768. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7997017

[5] McMurray, J. und Slattery, J. (1994): Scandinavian simvastatin study (4S), Lancet, (Band 344), No. 8939-8940, Seite 1765-6; author reply 1767-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7997012

[6] Gallis, B.; Corthals, G. L.; Goodlett, D. R.; Ueba, H.; Kim, F.; Presnell, S. R.; Figeys, D.; Harrison, D. G.; Berk, B. C.; Aebersold, R. und Corson, M. A. (1999): Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002, J Biol Chem, (Band 274), No. 42, Seite 30101-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10514497

[7] Glomset, J. A. (1968): The plasma lecithins:cholesterol acyltransferase reaction, J Lipid Res, (Band 9), No. 2, Seite 155-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4868699

[8] Yuhanna, I. S.; Zhu, Y.; Cox, B. E.; Hahner, L. D.; Osborne-Lawrence, S.; Lu, P.; Marcel, Y. L.; Anderson, R. G.; Mendelsohn, M. E.; Hobbs, H. H. und Shaul, P. W. (2001): High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase, Nat Med, (Band 7), No. 7, Seite 853-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11433352

[9] Gong, M.; Wilson, M.; Kelly, T.; Su, W.; Dressman, J.; Kincer, J.; Matveev, S. V.; Guo, L.; Guerin, T.; Li, X. A.; Zhu, W.; Uittenbogaard, A. und Smart, E. J. (2003): HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner, J Clin Invest, (Band 111), No. 10, Seite 1579-87. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12750408

[10] Goetzl, E. J. und An, S. (1998): Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate, Faseb J, (Band 12), No. 15, Seite 1589-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9837849

[11] Spiegel, S. und Merrill, A. H., Jr. (1996): Sphingolipid metabolism and cell growth regulation, Faseb J, (Band 10), No. 12, Seite 1388-97. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8903509

[12] Hla, T.; Lee, M. J.; Ancellin, N.; Paik, J. H. und Kluk, M. J. (2001): Lysophospholipids--receptor revelations, Science, (Band 294), No. 5548, Seite 1875-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11729304

[13] Chun, J.; Goetzl, E. J.; Hla, T.; Igarashi, Y.; Lynch, K. R.; Moolenaar, W.; Pyne, S. und Tigyi, G. (2002): International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature, Pharmacol Rev, (Band 54), No. 2, Seite 265-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12037142

[14] Mandala, S.; Hajdu, R.; Bergstrom, J.; Quackenbush, E.; Xie, J.; Milligan, J.; Thornton, R.; Shei, G. J.; Card, D.; Keohane, C.; Rosenbach, M.; Hale, J.; Lynch, C. L.; Rupprecht, K.; Parsons, W. und Rosen, H. (2002): Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists, Science, (Band 296), No. 5566, Seite 346-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11923495

[15] Matloubian, M.; Lo, C. G.; Cinamon, G.; Lesneski, M. J.; Xu, Y.; Brinkmann, V.; Allende, M. L.; Proia, R. L. und Cyster, J. G. (2004): Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1, Nature, (Band 427), No. 6972, Seite 355-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14737169

[16] Brinkmann, V.; Pinschewer, D.; Chiba, K. und Feng, L. (2000): FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation, Trends Pharmacol Sci, (Band 21), No. 2, Seite 49-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10664606

[17] Vitko, S. und Viklicky, O. (2004): Cyclosporine renal dysfunction, Transplant Proc, (Band 36), No. 2 Suppl, Seite 243S-247S. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15041346

[18] El-Hamamsy, I.; Grant, M.; Stevens, L. M.; Malo, O.; Carrier, M. und Perrault, L. P. (2005): Cyclosporine-induced coronary endothelial dysfunction: is tetrahydrobiopterin the solution?, Transplant Proc, (Band 37), No. 5, Seite 2365-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15964417

[19] Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K. und Masaki, T. (1988): A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, (Band 332), No. 6163, Seite 411-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2451132

[20] Miller, V. M. und Vanhoutte, P. M. (1985): Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase, Am J Physiol, (Band 248), No. 4 Pt 2, Seite H432-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3920919

[21] Cosentino, F.; Hishikawa, K.; Katusic, Z. S. und Luscher, T. F. (1997): High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, (Band 96), No. 1, Seite 25-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9236411

[22] Kaiser, R. A.; Oxhorn, B. C.; Andrews, G. und Buxton, I. L. (2002): Functional compartmentation of endothelial P2Y receptor signaling, Circ Res, (Band 91), No. 4, Seite 292-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12193461

[23] Johnsen, S. H.; Mathiesen, E. B.; Fosse, E.; Joakimsen, O.; Stensland-Bugge, E.; Njolstad, I. und Arnesen, E. (2005): Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study, Circulation, (Band 112), No. 4, Seite 498-504. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16027250

[24] Schulte, H.; Cullen, P. und Assmann, G. (1999): Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM), Atherosclerosis, (Band 144), No. 1, Seite 199-209. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10381293

[25] O'Connell, B. J. und Genest, J., Jr. (2001): High-density lipoproteins and endothelial function, Circulation, (Band 104), No. 16, Seite 1978-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11602504

[26] Spieker, L. E.; Sudano, I.; Hurlimann, D.; Lerch, P. G.; Lang, M. G.; Binggeli, C.; Corti, R.; Ruschitzka, F.; Luscher, T. F. und Noll, G. (2002): High-density lipoprotein restores endothelial function in hypercholesterolemic men, Circulation, (Band 105), No. 12, Seite 1399-402. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11914243

[27] Fleisher, L. N.; Tall, A. R.; Witte, L. D.; Miller, R. W. und Cannon, P. J. (1982): Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins, J Biol Chem, (Band 257), No. 12, Seite 6653-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7045092

[28] Dimmeler, S. und Zeiher, A. M. (1999): Nitric oxide-an endothelial cell survival factor, Cell Death Differ, (Band 6), No. 10, Seite 964-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10556973

[29] Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R. und Zeiher, A. M. (1999): Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, (Band 399), No. 6736, Seite 601-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10376603

[30] Boo, Y. C.; Sorescu, G.; Boyd, N.; Shiojima, I.; Walsh, K.; Du, J. und Jo, H. (2002): Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A, J Biol Chem, (Band 277), No. 5, Seite 3388-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11729190

[31] Haynes, M. P.; Sinha, D.; Russell, K. S.; Collinge, M.; Fulton, D.; Morales-Ruiz, M.; Sessa, W. C. und Bender, J. R. (2000): Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells, Circ Res, (Band 87), No. 8, Seite 677-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11029403

[32] Zachary, I. und Gliki, G. (2001): Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family, Cardiovasc Res, (Band 49), No. 3, Seite 568-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11166270

[33] Nofer, J. R.; Levkau, B.; Wolinska, I.; Junker, R.; Fobker, M.; von Eckardstein, A.; Seedorf, U. und Assmann, G. (2001): Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids, J Biol Chem, (Band 276), No. 37, Seite 34480-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11432865

[34] Mineo, C.; Yuhanna, I. S.; Quon, M. J. und Shaul, P. W. (2003): High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases, J Biol Chem, (Band 278), No. 11, Seite 9142-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12511559

[35] Dantas, A. P.; Igarashi, J. und Michel, T. (2003): Sphingosine 1-phosphate and control of vascular tone, Am J Physiol Heart Circ Physiol, (Band 284), No. 6, Seite H2045-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12742827

[36] Finigan, J. H.; Dudek, S. M.; Singleton, P. A.; Chiang, E. T.; Jacobson, J. R.; Camp, S. M.; Ye, S. Q. und Garcia, J. G. (2005): Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation, J Biol Chem, (Band 280), No. 17, Seite 17286-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15710622

[37] Nofer, J. R.; van der Giet, M.; Tolle, M.; Wolinska, I.; von Wnuck Lipinski, K.; Baba, H. A.; Tietge, U. J.; Godecke, A.; Ishii, I.; Kleuser, B.; Schafers, M.; Fobker, M.; Zidek, W.; Assmann, G.; Chun, J. und Levkau, B. (2004): HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3, J Clin Invest, (Band 113), No. 4, Seite 569-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14966566

[38] Fukushima, N.; Ishii, I.; Contos, J. J.; Weiner, J. A. und Chun, J. (2001): Lysophospholipid receptors, Annu Rev Pharmacol Toxicol, (Band 41), Seite 507-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11264467

[39] Levade, T.; Auge, N.; Veldman, R. J.; Cuvillier, O.; Negre-Salvayre, A. und Salvayre, R. (2001): Sphingolipid mediators in cardiovascular cell biology and pathology, Circ Res, (Band 89), No. 11, Seite 957-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11717151

[40] Yang, A. H.; Ishii, I. und Chun, J. (2002): In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice, Biochim Biophys Acta, (Band 1582), No. 1-3, Seite 197-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12069829

[41] Morales-Ruiz, M.; Lee, M. J.; Zollner, S.; Gratton, J. P.; Scotland, R.; Shiojima, I.; Walsh, K.; Hla, T. und Sessa, W. C. (2001): Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells, J Biol Chem, (Band 276), No. 22, Seite 19672-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11278592

[42] Lee, M. J.; Thangada, S.; Claffey, K. P.; Ancellin, N.; Liu, C. H.; Kluk, M.; Volpi, M.; Sha'afi, R. I. und Hla, T. (1999): Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate, Cell, (Band 99), No. 3, Seite 301-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10555146

[43] McGiffert, C.; Contos, J. J.; Friedman, B. und Chun, J. (2002): Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis, FEBS Lett, (Band 531), No. 1, Seite 103-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12401212

[44] Zhang, G.; Contos, J. J.; Weiner, J. A.; Fukushima, N. und Chun, J. (1999): Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate, Gene, (Band 227), No. 1, Seite 89-99. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9931453

[45] Ishii, I.; Fukushima, N.; Ye, X. und Chun, J. (2004): Lysophospholipid receptors: signaling and biology, Annu Rev Biochem, (Band 73), Seite 321-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15189145

[46] Ohmori, T.; Yatomi, Y.; Osada, M.; Kazama, F.; Takafuta, T.; Ikeda, H. und Ozaki, Y. (2003): Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2, Cardiovasc Res, (Band 58), No. 1, Seite 170-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12667959

[47] Brinkmann, V. und Lynch, K. R. (2002): FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity, Curr Opin Immunol, (Band 14), No. 5, Seite 569-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12183155

[48] Aki, F. T. und Kahan, B. D. (2003): FTY720: A new kid on the block for transplant immunosuppression, Expert Opin Biol Ther, (Band 3), No. 4, Seite 665-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12831371

[49] Paugh, S. W.; Payne, S. G.; Barbour, S. E.; Milstien, S. und Spiegel, S. (2003): The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2, FEBS Lett, (Band 554), No. 1-2, Seite 189-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14596938

[50] Kharel, Y.; Lee, S.; Snyder, A. H.; Sheasley-O'neill S, L.; Morris, M. A.; Setiady, Y.; Zhu, R.; Zigler, M. A.; Burcin, T. L.; Ley, K.; Tung, K. S.; Engelhard, V. H.; Macdonald, T. L. und Lynch, K. R. (2005): Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720, J Biol Chem. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16093248

[51] Busauschina, A.; Schnuelle, P. und van der Woude, F. J. (2004): Cyclosporine nephrotoxicity, Transplant Proc, (Band 36), No. 2 Suppl, Seite 229S-233S. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15041343

[52] Hwang, M. W.; Matsumori, A.; Furukawa, Y.; Ono, K.; Okada, M.; Iwasaki, A.; Hara, M. und Sasayama, S. (1999): FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation, Circulation, (Band 100), No. 12, Seite 1322-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10491378

[53] Motte, S.; Communi, D.; Pirotton, S. und Boeynaems, J. M. (1995): Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells, Int J Biochem Cell Biol, (Band 27), No. 1, Seite 1-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7757878

[54] Inscho, E. W.; Cook, A. K.; Mui, V. und Miller, J. (1998): Direct assessment of renal microvascular responses to P2-purinoceptor agonists, Am J Physiol, (Band 274), No. 4 Pt 2, Seite F718-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9575896

[55] Cameselle, J. C.; Costas, M. J.; Sillero, M. A. und Sillero, A. (1982): Bis-(5'-guanosyl) tetraphosphatase in rat tissues, Biochem J, (Band 201), No. 2, Seite 405-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6282267


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
13.11.2006